BioLife Plasma Services
BioLife Plasma Services | Longmont Colorado | Absolute Net | Investment Grade Tenant
Marketing description
Riverwest Real Estate Group is pleased to present the exclusive sale of a 16,694 SF BioLife Plasma Services facility on 3 acres at 478 S. Martin Street in Longmont, Colorado. The property is leased on an absolute net basis with zero landlord responsibilities, providing a true passive, bond-like income stream. BioLife — a wholly-owned subsidiary of Takeda Pharmaceutical (NYSE: TAK) and the largest national plasma collection operator with 200+ locations — has been in occupancy since 2015, demonstrating a 10+ year operating history at this location. The lease, guaranteed by investment-grade Baxalta, Inc., has 4.5 years remaining on the base term, features 3% rent escalations every three years (next bump October 2027), and includes three 5-year renewal options. The purpose-built, all-brick 2015-construction facility includes specialized labs, medical rooms, and 124 parking stalls supporting BioLife's high-volume donor model. Strategically positioned in the high-growth Denver/Boulder MSA along the US-287 corridor at the signalized intersection of Ken Pratt Blvd & S. Martin Rd. (58,693 VPD combined).
Investment highlights
1. Absolute Net Lease — Zero Landlord Responsibilities True passive, bond-like income stream with the tenant responsible for all real estate taxes, insurance, roof, structure, parking, and all maintenance, repair, and replacement obligations — providing the buyer with no capital exposure.
2. Investment-Grade Tenant — Backed by Takeda (NYSE: TAK) BioLife Plasma Services is a wholly-owned subsidiary of Takeda Pharmaceutical, one of the largest pharmaceutical companies in the world. The lease is guaranteed by Baxalta, Inc., providing investment-grade credit backing on the income stream.
3. Largest National Plasma Services Operator BioLife operates more than 200 plasma collection centers across North America, making it the dominant operator in the space and a mission-critical supplier to Takeda's plasma-derived therapies pipeline.
4. Long-Term Operating History — Tenant In Place Since 2015 BioLife has continuously operated at this location for 10+ years, demonstrating strong site-level performance, donor base, and commitment to the trade area — a key indicator of lease renewal probability.
5. Recession-Resistant, Needs-Based Healthcare Use Plasma collection is a non-discretionary, FDA-regulated medical use that proved resilient through every recent economic cycle. High regulatory and build-out barriers to entry create meaningful tenant stickiness.
6. 4.5 Years Remaining + Three (5-Year) Renewal Options Provides near-term certainty plus 15 years of additional optionality, giving a buyer a clear path to long-duration income with embedded growth.
7. Scheduled Rent Growth — 3% Every 3 Years Built-in rent escalations (next bump October 2027) provide an inflation hedge and steadily growing NOI through the base term and option periods.
8. Purpose-Built, Specialized Medical Facility A 16,694 SF all-brick building constructed in 2015 specifically for BioLife, featuring labs, medical rooms, specialized storage, and excellent ambient lighting — a costly, hard-to-replicate buildout that reinforces tenant retention.
9. Functional 3-Acre Site with 124 Parking Stalls Generously sized parcel with parking ratios well above retail/medical norms, supporting BioLife's high-volume, donor-on-demand operating model.
10. Strategic Denver/Boulder MSA Location Situated in Longmont — a high-growth Boulder MSA submarket benefiting from strong demographics, population growth, and economic expansion. Positioned along the US-287 corridor (a major N/S route from Wyoming to Oklahoma) at Ken Pratt Blvd & S. Martin Rd. with a combined 58,693 VPD and adjacent national tenancy.
Listing Contacts
Valuation Calculator
Valuation Metrics
Map
Broker Selected Comps View More Comps
Property History
Tax History
Similar Properties
Is there information that looks off?
